Literature DB >> 17115430

Bipolar disorder: improving diagnosis and optimizing integrated care.

J L Culver1, B A Arnow, T A Ketter.   

Abstract

Bipolar disorder is a chronic, severe condition commonly causing substantial mortality and psychosocial morbidity. Challenges in recognition can delay the institution of appropriate management, whereas misdiagnosis may initiate pharmacologic interventions that adversely affect the condition's course. Pharmacotherapy remains the foundation of treatment. In addition to efficacy, tolerability is an important consideration in medication choice, particularly for long-term maintenance because of its impact on adherence. Mood stabilizers are the classic treatments for bipolar disorder. Newer agents such as atypical antipsychotics may offer efficacy and/or tolerability advantages compared with other medications. The role of antidepressants in bipolar disorder remains controversial. Growing evidence indicates that adjunctive psychosocial interventions improve long-term functioning; consequently, psychologists are becoming increasingly involved in the long-term care of patients with bipolar disorder. This review seeks to update psychologists and related healthcare professionals on recent advances and the current limitations in the diagnosis and treatment of bipolar disorder. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17115430     DOI: 10.1002/jclp.20333

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  6 in total

1.  Clinical correlates of perinatal bipolar disorder in an interdisciplinary obstetrical hospital setting.

Authors:  Cynthia L Battle; Lauren M Weinstock; Margaret Howard
Journal:  J Affect Disord       Date:  2014-02-11       Impact factor: 4.839

2.  Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002.

Authors:  Jeffery A Demland; Yonghua Jing; Christina M L Kelton; Jeff J Guo; Hong Li; Patricia R Wigle
Journal:  Am Health Drug Benefits       Date:  2009-06

Review 3.  Problematic boundaries in the diagnosis of bipolar disorder: the interface with borderline personality disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

4.  What happens after diagnosis? Understanding the experiences of patients with newly-diagnosed bipolar disorder.

Authors:  Judith G Proudfoot; Gordon B Parker; Megan Benoit; Vijaya Manicavasagar; Meg Smith; Aimee Gayed
Journal:  Health Expect       Date:  2009-06       Impact factor: 3.377

5.  Cost-effectiveness of asenapine in the treatment of bipolar disorder in Canada.

Authors:  Jean Lachaine; Catherine Beauchemin; Karine Mathurin; Dominique Gilbert; Maud Beillat
Journal:  BMC Psychiatry       Date:  2014-01-22       Impact factor: 3.630

6.  Serum folate levels in bipolar disorder: a systematic review and meta-analysis.

Authors:  Yung-Chi Hsieh; Li-Shiu Chou; Ching-Hua Lin; Hung-Chi Wu; Dian-Jeng Li; Ping-Tao Tseng
Journal:  BMC Psychiatry       Date:  2019-10-22       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.